ALTIMMUNE, INC. Restructuring Reserve, Period Increase (Decrease)
ALTIMMUNE, INC. (ALT) reported Restructuring Reserve, Period Increase (Decrease) of -$66.63 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReservePeriodIncreaseDecrease · last filed 2017-05-03
- ALTIMMUNE, INC. restructuring reserve, period increase (decrease) for the quarter ending 2017-03-31 was -$66.63K.
- ALTIMMUNE, INC. restructuring reserve, period increase (decrease) for the quarter ending 2016-03-31 was -$196.72K, a 110.15% decline year-over-year.
- ALTIMMUNE, INC. restructuring reserve, period increase (decrease) for the quarter ending 2015-12-31 was -$319.01K.
- ALTIMMUNE, INC. restructuring reserve, period increase (decrease) for the quarter ending 2015-09-30 was $10.15K.
- ALTIMMUNE, INC. restructuring reserve, period increase (decrease) for fiscal 2016 was -$397.38K, a 182.49% decline from fiscal 2015.
- ALTIMMUNE, INC. restructuring reserve, period increase (decrease) for fiscal 2015 was $481.76K.
- ALTIMMUNE, INC. restructuring reserve, period increase (decrease) for fiscal 2014 was $0.00.
- ALTIMMUNE, INC. restructuring reserve, period increase (decrease) for fiscal 2013 was $0.00.
| Period end | Restructuring Reserve, Period Increase (Decrease) 3 month | Restructuring Reserve, Period Increase (Decrease) 6 month | Restructuring Reserve, Period Increase (Decrease) 9 month | Restructuring Reserve, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$66.63K 10-Q · filed 2017-05-03 | |||
| 2016-12-31 | -$397.38K 10-K · filed 2017-03-14 | |||
| 2016-03-31 | -$196.72K 10-Q · filed 2017-05-03 | -$515.72K derived: sum of 2 quarters · filed 2017-05-03 | -$505.57K derived: sum of 3 quarters · filed 2017-05-03 | -$1.61M derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | -$319.01K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$308.86K derived: sum of 2 quarters · filed 2017-03-14 | -$1.41M derived: sum of 3 quarters · filed 2017-03-14 | $481.76K 10-K · filed 2017-03-14 |
| 2015-09-30 | $10.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$1.09M derived: sum of 2 quarters · filed 2015-11-06 | $800.77K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | -$1.10M 10-Q · filed 2015-08-05 | $790.62K 10-Q · filed 2015-08-05 | ||
| 2015-03-31 | $1.94M 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-14 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |